Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites

por Wintzell, My, Hjerpe, Elisabet, Åvall Lundqvist, Elisabeth, Shoshan, Maria
Publicado 2012

Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study

por Engvall, Kristina, Gréen, Henrik, Fredrikson, Mats, Lagerlund, Magnus, Lewin, Freddi, Åvall-Lundqvist, Elisabeth
Publicado 2022

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer

por Gränsmark, Emma, Bågenholm Bylin, Nellie, Blomstrand, Hakon, Fredrikson, Mats, Åvall-Lundqvist, Elisabeth, Elander, Nils O.
Publicado 2020

Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer

por Isaksson, Jenny, Green, Henrik, Papantoniou, Dimitrios, Pettersson, Linn, Anden, Mats, Rosell, Johan, Åvall-Lundqvist, Elisabeth, Elander, Nils Oskar
Publicado 2021

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer

por Hjerpe, Elisabet, Egyhazi Brage, Suzanne, Carlson, Joseph, Frostvik Stolt, Marianne, Schedvins, Kjell, Johansson, Hemming, Shoshan, Maria, Åvall-Lundqvist, Elisabeth
Publicado 2013

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival

por Corvigno, Sara, Wisman, G. Bea A., Mezheyeuski, Artur, van der Zee, Ate G.J., Nijman, Hans W., Åvall-Lundqvist, Elisabeth, Östman, Arne, Dahlstrand, Hanna
Publicado 2016

Long‐term incidence of endometrial cancer after endometrial resection and ablation: A population based Swedish gynecologic cancer group (SweGCG) study

por Flöter Rådestad, Angelique, Dahm‐Kähler, Pernilla, Holmberg, Erik, Bjurberg, Maria, Hellman, Kristina, Högberg, Thomas, Kjölhede, Preben, Marcickiewicz, Janusz, Rosenberg, Per, Stålberg, Karin, Åvall‐Lundqvist, Elisabeth, Borgfeldt, Christer
Publicado 2022

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)

por Lindemann, Kristina, Gibbs, Emma, Åvall-Lundqvist, Elisabeth, dePont Christensen, Rene, Woie, Kathrine, Kalling, Marten, Auranen, Annika, Grenman, Seija, Hoegberg, Thomas, Rosenberg, Per, Skeie-Jensen, Tone, Hjerpe, Elisabet, Dørum, Anne, Gebski, Val, Kristensen, Gunnar
Publicado 2017

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study

por Lee, Yeh Chen, King, Madeleine T, O'Connell, Rachel L, Lanceley, Anne, Joly, Florence, Hilpert, Felix, Davis, Alison, Roncolato, Felicia T, Okamoto, Aikou, Bryce, Jane, Donnellan, Paul, Oza, Amit M, Avall-Lundqvist, Elisabeth, Berek, Jonathan S, Ledermann, Jonathan A, Berton, Dominique, Sehouli, Jalid, Feeney, Amanda, Kaminsky, Marie-Christine, Diamante, Katrina, Stockler, Martin R, Friedlander, Michael L
Publicado 2022